[1]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US5616620,1997,A
160296-13-9 | SB 205384 | AA00APSU | MFCD00918851
17795-26-5 | (2R)-3-(Allylsulfinyl)-2-aminopropanoic acid | AA00AQ4S | MFCD01311056
1539266-17-5 | 25B-NBF (hydrochloride) | AA00AQ9V
1437794-87-0 | Ethyl 7-bromo-1-ethyl-1,3-benzodiazole-5-carboxylate | AA00AQF7 | MFCD24448845
180045-91-4 | penigequinolone A | AA00AQIE | MFCD11111615
159426-95-6 | 8-Hydroxy Carvedilol | AA00AQZ7
1643915-62-1 | 4-[(5-Bromo-2-fluorobenzene)sulfonyl]morpholine | AA00ARKC | MFCD28805664
1469758-99-3 | TriethanolaMine-d12 | AA00AS41
149878-40-0 | Bifenazate oxidation type | AA00ASHS | MFCD30725512
1754-70-7 | 2-methyl-1-(3-methylphenyl)propan-2-ol | AA00AT3Q | MFCD11521058